Northwestern Medicine has announced a $10 million commitment from Michael and Tanya Polsky and their children in support of a new multidisciplinary institute dedicated to urologic cancers.
When up and running, the Polsky Urologic Cancer Institute of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital will offer a comprehensive approach to the treatment of urologic cancers, including prostate, bladder, kidney, and testicular, bringing together a multidisciplinary team of physicians and scientists to drive breakthroughs in treatment and accelerate new discoveries. Scheduled to open in early 2019, the institute also will provide patients with access to leading urologic cancer specialists and a wide range of services, including personalized, integrated, and innovative care.
"We believe that a patient-centric program that inspires leading-edge research will transform our field," said Edward Schaeffer, chair of urology at Northwestern Memorial and professor of urology at Northwestern University, who will lead the institute. "The Polsky Family Urologic Cancer Institute will become a multidisciplinary access point for cancer treatments, including surgery, chemo-, radio-, and immunotherapy as well a resource for genetic counseling, nutritional guidance and lifestyle management."
"This gift to create a Urologic Cancer Institute at Northwestern Medicine symbolizes my family's commitment to help others facing cancer come out on the winning side — and to ultimately eradicate the disease," said Michael Polsky, founder and CEO of Invenergy. "With this gift, we support Northwestern Medicine's vision to be the world's leader in diagnosing, advancing research breakthroughs and creating revolutionary treatments for urological cancers."
(Photo credit: Northwestern Medicine)